# Persistence of romosozumab vs. teriparatide in Japanese older adults aged ≥ 75 years with osteoporosis: a population-based cohort study.

> PubMed lists PMID 41400755 in Archives of osteoporosis as Journal Article, Comparative Study, with publication-date metadata of 2025-12-16 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-41400755-teriparatide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-07-13
- Source checked: 2026-08-10
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-41400755-teriparatide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-41400755-teriparatide-v1.json
- Content SHA-256: `91715e8a469e0fc2a4c2095d20eab223c348dda142793669d4f6d34fefdc8aa2`

## Claims and source pins

### Headline

Persistence of romosozumab vs. teriparatide in Japanese older adults aged ≥ 75 years with osteoporosis: a population-based cohort study. ([`pubmed-observation-pmid-41400755-2026-07-13-94464d7c3554`](#source-pubmed-observation-pmid-41400755-2026-07-13-94464d7c3554))

### Summary

PubMed lists PMID 41400755 in Archives of osteoporosis as Journal Article, Comparative Study, with publication-date metadata of 2025-12-16 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-41400755-2026-07-13-94464d7c3554`](#source-pubmed-observation-pmid-41400755-2026-07-13-94464d7c3554))

### Paragraph 1

PubMed lists PMID 41400755 in Archives of osteoporosis as Journal Article, Comparative Study, with publication-date metadata of 2025-12-16 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-41400755-2026-07-13-94464d7c3554`](#source-pubmed-observation-pmid-41400755-2026-07-13-94464d7c3554))

### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-41400755-2026-07-13-94464d7c3554`](#source-pubmed-observation-pmid-41400755-2026-07-13-94464d7c3554))

## Sources

<a id="source-pubmed-observation-pmid-41400755-2026-07-13-94464d7c3554"></a>
- **Persistence of romosozumab vs. teriparatide in Japanese older adults aged ≥ 75 years with osteoporosis: a population-based cohort study. · retained source version 1:2026-07-13:current:94464d7c3554ad2e6441b5e68666164e9ec330a5cb3f96f4b14d947ea54fa017** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/41400755/) (`pubmed-observation-pmid-41400755-2026-07-13-94464d7c3554`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "Persistence of romosozumab vs. teriparatide in Japanese older adults aged ≥ 75 years with osteoporosis: a population-based cohort study." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-41400755-teriparatide-v1.json SHA-256: 91715e8a469e0fc2a4c2095d20eab223c348dda142793669d4f6d34fefdc8aa2.